Kasap, N. Et Al. 2022. A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis. Clinical and Experimental Allergy , vol.52, no.7 , 907-910.

Kasap, N., ASLAN, K., Karakurt, L. T., Bozkurt, H., CANATAN, H., Cavkaytar, O., ... EKEN, A.(2022). A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis. Clinical and Experimental Allergy , vol.52, no.7, 907-910.

Kasap, Nurhan Et Al. "A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis," Clinical and Experimental Allergy , vol.52, no.7, 907-910, 2022

Kasap, Nurhan Et Al. "A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis." Clinical and Experimental Allergy , vol.52, no.7, pp.907-910, 2022

Kasap, N. Et Al. (2022) . "A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis." Clinical and Experimental Allergy , vol.52, no.7, pp.907-910.

@article{article, author={Nurhan Kasap Et Al. }, title={A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis}, journal={Clinical and Experimental Allergy}, year=2022, pages={907-910} }